Ideas to Action:

Independent research for global prosperity

Multimedia

CGD's weekly Global Prosperity Wonkcast, event videos, whiteboard talks, slides, and more.

Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases (Event Video)

Pak Report

An estimated one billion people suffer from one or more neglected diseases like Tuberculosis, Malaria, Dengue Fever or others, and hundreds of millions of dollars have been spent to find effective treatments. Medicines, therapies and treatments have been discovered, but regulatory barriers in the late-stage clinical trials of developing countries have prevented these drugs from helping those in need.

Finding the Funding for GAVI: Amanda Glassman

Amanda Glassman

My guest on this show is Amanda Glassman, research fellow and director of CGD’s Global Health Program. I recorded this Wonkcast with her last week, just ahead of the first pledging session for the Global Alliance for Vaccines and Immunizations (GAVI). 

GAVI is a coalition of private foundations and donor country governments who work to increase the availability of vaccines, a highly cost-effective health intervention that is chronically under provided. Among other mechanisms, GAVI buys the vaccines at discount by purchasing in bulk, then passes the savings onto poor countries and expanding coverage. Over the past 10 years, GAVI estimates it has saved 5 million children from vaccine vaccine-preventable diseases, an accomplishment which Amanda considers to be remarkable.

Innovation in Vaccine Financing: Assessing Progress and Envisioning Future Directions (Event Video)

Alice Albright

In a recent speech, USAID Administrator Rajiv Shah said “The evidence is clear: vaccines are the best public health investment we can make.” As the Global Alliance for Vaccines and Immunization (GAVI) prepares for its June 2011 pledging conference, CGD hosted a panel to look back at global efforts to support vaccination funding in developing countries over the past decade and reflect on lessons learned and future potential. The panel also looked to the issues and challenges facing vaccination financing in the 2010s.

Rationing Health Care the NICE Way (Event Video)

CGD is pleased to host Sir Andrew Dillon, chief executive of the UK National Institute for Health and Clinical Excellence (NICE), and Dr. Kalipso Chalkidou, Director of NICE International, to discuss the relevance of institutions such as NICE to improving value for money in health and the characteristics, strengths and limitations of current institutions in the developed and developing world.

The Year Ahead in Global Health at CGD: Amanda Glassman

Amanda GlassmanTo mark the start of the new year, my guest is Amanda Glassman, CGD’s new director of global health. I asked Amanda, who previously worked at the Inter-American Development Bank, the Brookings Institution, and USAID, where she sees opportunities for progress on global health in 2011 and beyond.

Amanda summarizes her priorities for CGD’s global health program with two big questions. First, how can donors deploy their global health aid budgets (more constrained than ever) to have the greatest impact on health in poor countries? Second, how can these same donors help poor countries and poor people use their own resources more effectively?